Cite
HARVARD Citation
Ye, Q. et al. (2021). Sirolimus-based immunosuppression improves the prognosis of liver Transplantation Recipients with low TSC1/2 expression in hepatocellular carcinoma beyond the Milan Criteria. European journal of surgical oncology. 47 (10), pp. 2533-2542. [Online].